Literature DB >> 23624585

Human papillomavirus vaccine and systemic lupus erythematosus.

Mariele Gatto1, Nancy Agmon-Levin, Alessandra Soriano, Raffaele Manna, Ramit Maoz-Segal, Shaye Kivity, Andrea Doria, Yehuda Shoenfeld.   

Abstract

To investigate the association between human papillomavirus (HPV) vaccination and autoimmune manifestations compatible with systemic lupus erythematosus (SLE) or SLE-like disease, the medical history of six women who presented with SLE or SLE-like disease following HPV immunization was collected. Data regarding type of vaccine, number of immunization, family and personal, clinical and serological features, as well as response to treatments were analyzed. In the reported cases, several common features were observed, such as personal or familial susceptibility to autoimmunity or adverse response to a prior dose of the vaccine, both of which may be associated with a higher risk of post-vaccination autoimmunity. Favorable response to immunosuppressant was observed in all patients. In the current study, a temporal association between immunization with HPV vaccine and the appearance of a spectrum of SLE-like conditions is reported. Additionally, among the patients described, several common features were observed that may enable better identification of subjects at risk. Further studies are required to assess the safety of immunization with the HPV vaccine in patients with autoimmune-rheumatic diseases or in subject at risk of autoimmunity as well as the potential beneficial effect of preventive immunosuppressants.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23624585     DOI: 10.1007/s10067-013-2266-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  44 in total

Review 1.  'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants.

Authors:  Yehuda Shoenfeld; Nancy Agmon-Levin
Journal:  J Autoimmun       Date:  2010-08-13       Impact factor: 7.094

Review 2.  Vaccines and autoimmunity.

Authors:  Nancy Agmon-Levin; Ziv Paz; Eitan Israeli; Yehuda Shoenfeld
Journal:  Nat Rev Rheumatol       Date:  2009-11       Impact factor: 20.543

Review 3.  SLE diagnosis and treatment: when early is early.

Authors:  Andrea Doria; Margherita Zen; Mariagrazia Canova; Silvano Bettio; Nicola Bassi; Linda Nalotto; Mariaelisa Rampudda; Anna Ghirardello; Luca Iaccarino
Journal:  Autoimmun Rev       Date:  2010-09-08       Impact factor: 9.754

4.  Systemic lupus erythematosus following HPV immunization or infection?

Authors:  H F Soldevilla; S F R Briones; S V Navarra
Journal:  Lupus       Date:  2012-02       Impact factor: 2.911

Review 5.  Immunization of patients with autoimmune inflammatory rheumatic diseases (the EULAR recommendations).

Authors:  S van Assen; M Bijl
Journal:  Lupus       Date:  2012-02       Impact factor: 2.911

Review 6.  Vaccines and autoimmune diseases of the adult.

Authors:  Hedi Orbach; Nancy Agmon-Levin; Gisele Zandman-Goddard
Journal:  Discov Med       Date:  2010-02       Impact factor: 2.970

7.  The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.

Authors:  Darron R Brown; Susanne K Kjaer; Kristján Sigurdsson; Ole-Erik Iversen; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Laura A Koutsky; Eng Hseon Tay; Patricía Garcia; Kevin A Ault; Suzanne M Garland; Sepp Leodolter; Sven-Eric Olsson; Grace W K Tang; Daron G Ferris; Jorma Paavonen; Marc Steben; F Xavier Bosch; Joakim Dillner; Elmar A Joura; Robert J Kurman; Slawomir Majewski; Nubia Muñoz; Evan R Myers; Luisa L Villa; Frank J Taddeo; Christine Roberts; Amha Tadesse; Janine Bryan; Lisa C Lupinacci; Katherine E D Giacoletti; Heather L Sings; Margaret James; Teresa M Hesley; Eliav Barr
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

Review 8.  Adjuvants and autoimmunity.

Authors:  E Israeli; N Agmon-Levin; M Blank; Y Shoenfeld
Journal:  Lupus       Date:  2009-11       Impact factor: 2.911

9.  Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines.

Authors:  Thomas Verstraeten; Dominique Descamps; Marie-Pierre David; Toufik Zahaf; Karin Hardt; Patricia Izurieta; Gary Dubin; Thomas Breuer
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

10.  AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland.

Authors:  Hanna Nohynek; Jukka Jokinen; Markku Partinen; Outi Vaarala; Turkka Kirjavainen; Jonas Sundman; Sari-Leena Himanen; Christer Hublin; Ilkka Julkunen; Päivi Olsén; Outi Saarenpää-Heikkilä; Terhi Kilpi
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

View more
  31 in total

Review 1.  Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background.

Authors:  Susanna Esposito; Elisabetta Prada; Maria Vincenza Mastrolia; Giusyda Tarantino; Claudio Codecà; Donato Rigante
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2. 

Authors:  Norbert Wagner; Frauke Assmus; Gabriele Arendt; Erika Baum; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Dirk Föll; Edeltraut Garbe; Jane Hecht; Ulf Müller-Ladner; Tim Niehues; Klaus Überla; Sabine Vygen-Bonnet; Thomas Weinke; Miriam Wiese-Posselt; Michael Wojcinski; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-04       Impact factor: 1.513

Review 3.  Addressing HPV vaccine myths: practical information for healthcare providers.

Authors:  Robert A Bednarczyk
Journal:  Hum Vaccin Immunother       Date:  2019-02-20       Impact factor: 3.452

Review 4.  Rapidly progressive diffuse systemic sclerosis after local vitamins A, D and E complex injections: literature review and report of two cases.

Authors:  Gustavo Guimarães Moreira Balbi; Ricardo Azêdo Montes; Verônica Silva Vilela; Marcella Azevedo Borges Andrade; Monisa Martins Nóbrega; Luna Azulay-Abulafia; Roberto Souto da Silva; Evandro Mendes Klumb; Roger Abramino Levy
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 5.  A review on SLE and malignancy.

Authors:  May Y Choi; Kelsey Flood; Sasha Bernatsky; Rosalind Ramsey-Goldman; Ann E Clarke
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-11-10       Impact factor: 4.098

Review 6.  Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction.

Authors:  Yahel Segal; Yehuda Shoenfeld
Journal:  Cell Mol Immunol       Date:  2018-03-05       Impact factor: 11.530

Review 7.  Vaccination of patients with autoimmune inflammatory rheumatic diseases.

Authors:  Johanna Westra; Christien Rondaan; Sander van Assen; Marc Bijl
Journal:  Nat Rev Rheumatol       Date:  2014-12-09       Impact factor: 20.543

8.  Should we target patients with autoimmune diseases for human papillomavirus vaccine uptake?

Authors:  Candace H Feldman; Seoyoung C Kim
Journal:  Expert Rev Vaccines       Date:  2014-06-17       Impact factor: 5.217

9.  Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice.

Authors:  Shaye Kivity; Maria-Teresa Arango; Nicolás Molano-González; Miri Blank; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

10.  [Guidelines for vaccination of immunocompromised individuals].

Authors:  Ursula Wiedermann; Harald H Sitte; Heinz Burgmann; Alexander Eser; Petra Falb; Heidemarie Holzmann; Maria Kitchen; Marcus Köller; Herwig Kollaritsch; Michael Kundi; Hans Lassmann; Ingomar Mutz; Winfried F Pickl; Elisabeth Riedl; Maria Sibilia; Florian Thalhammer; Barbara Tucek; Werner Zenz; Karl Zwiauer
Journal:  Wien Klin Wochenschr       Date:  2016-07-25       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.